Chicago, Illinois
United States
7
2023-06-08
7
2025-08-26
These are the the leading inventors for applications assigned to AltaThera Pharmaceuticals LLC:
AltaThera Pharmaceuticals LLC based in Chicago, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ANTI-ARRHYTHMIC COMPOSITIONS AND METHODS
#2 | 2023-03-09 ✅ Patent 11,610,660 granted on 2023-03-21Antiarrhythmic drug dosing methods, medical devices, and systems
#3 | 2022-08-04 ✅ Patent 12,403,109 granted on 2025-09-02SOTALOL HYDROCHLORIDE DOSING
#4 | 2020-10-29 ✅ Patent 11,344,518 granted on 2022-05-31Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
#5 | 2020-03-26 ✅ Patent 11,696,902 granted on 2023-07-11Method of initiating and escalating sotalol hydrochloride dosing
#6 | 2020-03-19 ✅ Patent 12,390,431 granted on 2025-08-19Method of Initiating and Escalating Sotalol Hydrochloride Dosing
#7 | 2019-12-24 ✅ Patent 10,512,620 granted on 2019-12-24Method of initiating and escalating sotalol hydrochloride dosing
Also check out AltaThera Pharmaceuticals LLC's (Chicago, United States) applicant profile with 13 patent applications submitted.
379559 ⎘